Pfizer Inc.
PFE
$26.32
$0.3751.45%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2024 | 09/29/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -90.82% | 10,790.24% | -98.68% | 192.46% | -41.44% |
| Total Depreciation and Amortization | 2.35% | 1.16% | -0.29% | 3.96% | 7.14% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 523.61% | -2,592.86% | 96.67% | 72.06% | -127.49% |
| Change in Net Operating Assets | 232.88% | 124.87% | -5.97% | -139.48% | 804.75% |
| Cash from Operations | 0.10% | 476.98% | -263.39% | -79.20% | 51.62% |
| Capital Expenditure | -40.86% | -2.20% | 9.52% | 32.57% | -28.89% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 49.79% | -126.85% | 114.98% | -92.72% | 1,870.14% |
| Cash from Investing | 21.10% | -144.72% | 165.59% | 115.75% | -1,338.29% |
| Total Debt Issued | -66.13% | -52.71% | 216.48% | -81.18% | 34,972.73% |
| Total Debt Repaid | 21.74% | 3.82% | -26.79% | -3,611.65% | 107.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | 0.00% | -0.34% | -2.46% | -0.04% |
| Other Financing Activities | -133.33% | 90.48% | 83.68% | -2,044.44% | 51.35% |
| Cash from Financing | -10.31% | -88.53% | 50.13% | -190.61% | 244.01% |
| Foreign Exchange rate Adjustments | -422.22% | 150.00% | 35.71% | -2,700.00% | 96.88% |
| Miscellaneous Cash Flow Adjustments | -- | -200.00% | -- | -- | -100.00% |
| Net Change in Cash | -255.17% | -91.55% | 116.05% | -578.41% | -158.88% |
